Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
1.46 EUR | 0.00% | +2.10% | +13.18% |
02.05. | ATyr Pharma, Inc. meldet Ergebnis für das erste Quartal zum 31. März 2024 | CI |
15.03. | ATYR PHARMA, INC. : RBC Capital Markets bekräftigt seine Kaufempfehlung | ZM |
5-Tages-Kurse
verzögerte Kurse Deutsche Boerse AG30.04.2024 | 02.05.2024 | 03.05.2024 | 06.05.2024 | |
---|---|---|---|---|
Kurs | 1.46 € | 1.44 € | 1.46 € | 1.46 € |
Veränderung | +2.10% | -1.37% | +1.39% | 0.00% |
Performance
1 Woche | +2.10% | ||
1 Monat | -13.61% | ||
3 Monate | -5.19% | ||
6 Monate | +24.79% | ||
Laufendes Jahr | +13.18% | ||
1 Jahr | -21.51% | ||
3 Jahre | -53.50% | ||
5 Jahre | -80.79% |
Volumen
MärkteBasisdaten
Extremkurse
Indikatoren
Sektorenvergleich - Biotechnologie und medizinische Forschung - Andere
Name | % | % 5 Tage | % 1. Jan. | % 1 Jahr | Kap. | |
---|---|---|---|---|---|---|
0.00% | +2.10% | +13.18% | -21.51% | 109 Mio. | ||
-2.30% | +9.42% | +22.81% | -10.88% | 47.9 Mrd. | ||
-0.23% | -0.77% | +46.56% | -10.68% | 41.42 Mrd. | ||
+1.64% | -3.58% | -1.88% | +20.43% | 40.7 Mrd. | ||
+0.80% | +2.89% | -6.20% | +15.95% | 28.92 Mrd. | ||
+1.98% | +3.62% | +11.33% | +66.05% | 25.55 Mrd. | ||
-0.73% | +2.62% | -21.00% | -28.69% | 19.27 Mrd. | ||
-1.59% | +17.90% | -1.43% | -8.50% | 12.15 Mrd. | ||
+2.08% | +0.13% | +30.73% | +93.79% | 12.14 Mrd. | ||
+0.77% | +1.37% | -0.48% | +23.02% | 11.99 Mrd. | ||
-0.72% | +9.34% | +18.47% | +21.67% | 11.64 Mrd. | ||
-0.93% | +0.66% | -4.90% | -10.17% | 9.53 Mrd. | ||
-2.86% | +5.23% | +36.16% | +60.44% | 6.85 Mrd. | ||
-0.88% | +14.12% | +15.19% | +88.96% | 6.71 Mrd. | ||
+0.68% | -0.37% | +24.46% | -22.95% | 6.66 Mrd. | ||
+4.47% | +3.49% | +12.33% | -29.83% | 6.6 Mrd. | ||
Durchschnitt | +0.30% | +5.44% | +12.21% | +15.44% | ||
Gewichteter Durchschnitt nach Marktkapitalisierung | +0.48% | +4.05% | +13.06% | +12.46% |
Historische Daten
Datum | Eröffnung | Hoch | Tief | Schlusskurs | Volumen |
---|
Monatliche Veränderungen
Jährliche Veränderungen
2024 | +13.18% | ||
2023 | -32.67% | ||
2022 | -69.83% | ||
2021 | +95.99% | ||
2020 | -15.18% | ||
2019 | -35.03% | ||
2018 | -86.39% | ||
2017 | +47.35% | ||
2016 | -21.21% |
- Börse
- Aktien
- A2PM86 Aktie
- A2PM86 Aktie
- Kurse aTyr Pharma, Inc.